ReviewJournal of clinical medicine2021

Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development.

Alessia Virzì et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.